The adjuvant HIPEC procedure is considered to be the evolution of a treatment strategy which originated in the 1980s. In the era of 5-FU as the only available cytotoxic agent for CRC, adjuvant intraperitoneal chemotherapy has been investigated, using administration of 5-FU through peritoneal catheter in the immediate postoperative period or as prolonged treatment up to 12 months